Rebers
Frank Rebers, Utrecht NL
Patent application number | Description | Published |
---|---|---|
20090275126 | ANTIBODIES AGAINST INSULIN-LIKE GROWTH FACTOR I RECEPTOR AND USES THEREOF - Antibodies against insulin like growth factor I receptor (IGF-IR), methods for their production, pharmaceutical compositions containing said antibodies, and uses for such antibodies are disclosed. Such antibodies are implicated in antitumor therapy. | 11-05-2009 |
20100166740 | Anti-OX40L antibodies - This invention relates to anti-OX40L antibodies and, in particular, to anti-OX40L antibodies and variants thereof that contain a Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from inflammatory diseases. | 07-01-2010 |
20110070239 | ANTI-OX40L ANTIBODIES - This invention relates to anti-OX40L antibodies and, in particular, to anti-OX40L antibodies and variants thereof that contain a Fc part derived from human origin and do not bind complement factor C | 03-24-2011 |
20110086026 | ANTIBODIES AGAINST IL-13 RECEPTOR ALPHA 1 AND USES THEREOF - An antibody binding to IL-13Rα1, inhibiting IL-13 bioactivity and comprising a variable heavy and a variable light chain, characterized in that the variable heavy chain amino acid sequence CDR3 of said antibody is selected from the group consisting of the heavy chain CDR3 sequences of SEQ ID NO: 1, 3, 5, 7 or 9 is useful in the treatment of asthma and allergic diseases. | 04-14-2011 |
Frank Rebers, Baettwil CH
Patent application number | Description | Published |
---|---|---|
20090311779 | ANTI-P-SELECTIN ANTIBODIES - This invention relates to anti-P-selectin antibodies and, in particular, to anti-P-selectin antibodies and variants thereof that contain an Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from critical limb ischemia or peripheral arterial occlusive disease (CLI/PAOD). | 12-17-2009 |
Frank Everhardus Martinus Rebers, Utrecht NL
Patent application number | Description | Published |
---|---|---|
20110038869 | MONOCLONAL ANTIBODIES AGAINST CD32B - Isolated monoclonal antibodies which bind to human CD32b and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, and therapeutic and diagnostic methods for using the antibodies. | 02-17-2011 |
Kenneth D. Rebers, Austin, TX US
Patent application number | Description | Published |
---|---|---|
20100086260 | OPTICAL FIBER CABLE INLET DEVICE AND TELECOMMUNICATIONS ENCLOSURE SYSTEM - An inlet device is described for inserting a cable containing optical fibers into a telecommunications enclosure. The inlet device includes a housing with a strength member securing section configured to fasten at least one strength member to the housing. The inlet device further includes a fiber guide device. The inlet device may be used in a single fiber optical cable assembly or multi-fiber optical cable assembly. A method for preparing a cable assembly is also described. A telecommunications enclosure including an inlet device is also described. | 04-08-2010 |
Kenneth D. Rebers, Georgetown, TX US
Patent application number | Description | Published |
---|---|---|
20120008257 | CELL TOWER WIRING JUNCTION BOX - An enclosure for protecting transitioning cell tower cables comprises a base and a cover coupled to the base via a hinge. The base and the cover form an interior cavity when placed in a closed position. The enclosure further includes at least one entrance port formed in at least a portion of a front end of at least one of the base and the cover. The enclosure further includes a plurality of exit ports, wherein a first set of exit ports are formed in a first side wall of the enclosure and a second set of exit ports are formed in a second side wall of the enclosure. The entrance port(s) is/are configured to receive a first cable comprising multiple lines. The plurality of exit ports are each configured to receive at least one individual line from the multiple lines. In another aspect, one or more support plates are disposed in the interior cavity, where a plurality of strain relief brackets are mounted to the support plate(s) and are configured to clamp individual lines from the first cable to the one or more support plates. | 01-12-2012 |